Sebastian Schneeweiss
Professor in the Department of Epidemiology
Epidemiology, Harvard T.H. Chan School of Public Health
Departments
Department of Epidemiology
Other Positions
Professor of Medicine
Medicine-Brigham and Women's Hospital, Harvard Medical School
Professor of Biomedical Informatics
Biomedical Informatics, Harvard Medical School
Related Links
Biography
Sebastian Schneeweiss is a Professor of Medicine at Harvard Medical School and holds the Emmanuel Janssen Chair for the Evaluation of Medicines. He is Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics, a world-leading research and training center in the Department of Medicine, Mass General Brigham.
His research is funded by multiple NIH, PCORI, BWF, and FDA grants and focuses on the comparative effectiveness and safety of biopharmaceuticals. He has developed analytic methods to improve the scientific validity of epidemiologic analyses using complex longitudinal healthcare databases, particularly for newly marketed medical products. Applying such methods in rapid analysis cycles for sequential medication effectiveness monitoring and rapid response analyses is the overarching theme of his research. He is Aetion Inc.’s co-founder, now Datavant, where he developed a range of rapid-cycle analytics platforms for healthcare database networks around the world.
Dr. Schneeweiss is PI of the Sentinel Innovation Center funded by FDA/CDER, where he is a voting consultant to the FDA Drug Safety and Risk Management Advisory Committee. He was an inaugural member of the Methods Committee of the Patient-Centered Outcomes Research Institute. He is Past President of the International Society for Pharmacoepidemiology and is a Fellow of the American College of Epidemiology, the American College of Clinical Pharmacology, and the International Society for Pharmacoepidemiology.
At Harvard, he teaches courses on Database Analytics for Pharmacoepidemiology (EPI286), Effectiveness Research in Longitudinal Healthcare Databases (EPI253), Foundations of Clinical Data (BMIF204), and Medications and Evidence (AISC604), among others.
He received his medical training at the University of Munich and his doctoral degree from Harvard.